MP

Mark Potts

Mr Potts is a leading global technology and business executive. He has founded multiple venture backed technology and technology services companies in Australia, the UK and the US. Most recently Mr Potts was an HP Fellow and Chief Technology Officer / Vice President of Corporate Strategy at Hewlett-Packard Enterprise in the US, leading their efforts in both M&A, technology investment and capital strategy. Mr Potts is also a non-executive director at Linear Clinical Research Limited, a purpose built state-of-the-art, clinical trials facility and a focal point for Australian clinical and medical research. Mr Potts is a Member of the Australian Institute of Company Directors. He is a member of the Risk committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
12/12/22234,8390N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
12/12/22
Issued
111,298$0.160$17,807Rights issue
08/09/21
Transfer
79,097$0.450$35,593Off-market transfer
08/09/21
Buy
44,444$0.450$19,999On-market trade
08/09/21
Transfer
79,097$0.450$35,593Off-market transfer
03/03/20
Issued
27,272$1.100$30,000Participation in share purchase plan